<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE TEI.2 SYSTEM "tei_bawe.dtd"><TEI.2 id="_6119b" n="version 1.0"><teiHeader><fileDesc><titleStmt><title>Experiment 5- ELISA</title></titleStmt><extent/><publicationStmt><distributor>British Academic Written English (BAWE) corpus</distributor><availability><p>The British Academic Written English (BAWE) corpus was developed at the Universities of Warwick, Reading and Oxford Brookes, under the directorship of Hilary Nesi and Sheena Gardner (formerly of the Centre for Applied Linguistics [previously called CELTE], Warwick), Paul Thompson (Department of Applied Linguistics, Reading) and Paul Wickens (Westminster Institute of Education, Oxford Brookes), with funding from the ESRC. Subject to the rights of the these institutions in the BAWE corpus, and pursuant to the ESRC agreement, the BAWE corpus is available to researchers for research purposes PROVIDED THAT the following conditions are met:</p><p>1. The corpus files are not distributed in either their original form or in modified form.</p><p>2. The texts are used for research purposes only; they should not be reproduced in teaching materials.</p><p>3. The texts are not reproduced in full for a wider audience/readership, although researchers are free to quote short passages of text (up to 200 running words from any given text).</p><p>4. The BAWE corpus developers (contact: Hilary Nesi) are informed of all projects, dissertations, theses, presentations or publications arising from analysis of the corpus.</p><p>5. Researchers acknowledge their use of the corpus using the following form of words: "The data in this study come from the British Academic Written English (BAWE) corpus, which was developed at the Universities of Warwick, Reading and Oxford Brookes under the directorship of Hilary Nesi and Sheena Gardner (formerly of the Centre for Applied Linguistics [previously called CELTE], Warwick), Paul Thompson (Department of Applied Linguistics, Reading) and Paul Wickens (Westminster Institute of Education, Oxford Brookes), with funding from the ESRC (RES-000-23-0800)."</p></availability></publicationStmt><notesStmt><note resp="British Academic Written English (BAWE) corpus project">Evaluated as candidate compound assignment. Assigned to S4: set of tasks/questions/exercises: non-compound.</note><note resp="British Academic Written English (BAWE) corpus project">Page header contains: student name. </note><note resp="British Academic Written English (BAWE) corpus project">answer to question 1 ("see attached"): refers to computer printout of experiment results (not available in the corpus) 
</note></notesStmt><sourceDesc><p n="level">1</p><p n="date">2006-04</p><p n="module title">Practical biochemistry</p><p n="module code">AM1M13</p><p n="genre family">Exercise</p><p n="discipline">Biological Sciences</p><p n="disciplinary group">LS</p><p n="grade">D</p><p n="number of authors">1</p><p n="number of words">497</p><p n="number of s-units">23</p><p n="number of p">13</p><p n="number of tables">0</p><p n="number of figures">0</p><p n="number of block quotes">0</p><p n="number of formulae">3</p><p n="number of lists">0</p><p n="number of paragraphs formatted like lists">0</p><p n="abstract present">no abstract</p><p n="average words per s-unit">21.6</p><p n="average s-units per p">1.8</p><p n="macrotype of assignment">complex but non-compound assignment (see notesStmt for details)</p></sourceDesc></fileDesc><encodingDesc><p>TEI P4 (documented in: BAWE.documentation.pdf)</p></encodingDesc><profileDesc><particDesc><person><p n="gender">f</p><p n="year of birth">1985</p><p n="first language">English</p><p n="education">UKa</p><p n="course">BSC pathobiology</p><p n="student ID">6119</p></person></particDesc></profileDesc></teiHeader><text><front><titlePage><docTitle><titlePart rend="underlined">Experiment 5- <hi rend="bold">ELISA</hi></titlePart></docTitle></titlePage></front><body><div1 type="section"><head rend="bold">1) </head><p n="p1.13"><s n="s1.1;p1.13">See attached. </s></p></div1><div1 type="section"><head rend="bold">2) </head><p n="p2.13"><s n="s1.1;p2.13">The linear part of the standard curve can be identified with a concentration range of 10-20 Î¼g/ml, with consideration for the accuracy of the following calculations. </s></p></div1><div1 type="section"><head rend="bold">3) </head><p n="p3.13"><s n="s1.1;p3.13">The dilutions that appeared to give the most accurate values were plate 3 (x2 dilution), plate 4 (x4 dilution) and plate 5 (x8 dilution). </s></p></div1><div1 type="section"><head rend="bold">4) </head><p n="p4.13"><s rend="underlined" n="s1.1;p4.13">Results from unknown 1. </s></p><p n="p5.13"><s n="s1.1;p5.13"><formula notation="" id="BAWE_6119b-form.001"/> </s></p></div1><div1 type="section"><head rend="bold">5) </head><p n="p6.13"><s rend="underlined" n="s1.1;p6.13">Results from unknown 2 </s></p><p n="p7.13"><s n="s1.1;p7.13"><formula notation="" id="BAWE_6119b-form.002"/> </s></p><p n="p8.13"><s n="s1.1;p8.13">The difference in concentration between the averages of unknown 1 and unknown 2 is <formula notation="" id="BAWE_6119b-form.003"/>, therefore it has approximately a 25 fold difference. </s></p></div1><div1 type="section"><head rend="bold">6) </head><p n="p9.13"><s n="s1.2;p9.13">The competitive nature of the antibody and the enzyme will cause the experiment to continue progressively over time. </s><s n="s2.2;p9.13">If the reaction time is allowed to differ in each well, the results would be inaccurate and therefore comparing concentrations be invalid. </s></p></div1><div1 type="section"><head rend="bold">7) </head><p n="p10.13"><s n="s1.1;p10.13">The ELISA has the advantage of being able to detect the antigen and the quantities of it in an unknown, but simple solution, whereas Western blots are only good for detecting small amounts of protein in a complex sample, which is not as useful a method for quantifying. </s></p></div1><div1 type="section"><head rend="bold">8) </head><p n="p11.13"><s n="s1.6;p11.13">In order to determine whether or not the monoclonal antibodies recognise Protein X in its pure and denatured forms, an ELISA would have to be set up, similar to the one carried out in this practical. </s><s n="s2.6;p11.13">The antibodies would be diluted along the rows, with a duplicate row to improve accuracy. </s><s n="s3.6;p11.13">So in total, four rows of wells will be used with two different experiments being carried out. </s><s n="s4.6;p11.13">The wells would then be combined with the two variants of protein X and the level of agglutination would be measured. </s><s n="s5.6;p11.13">This would allow a comparison to be measured between the reaction with the pure and denatured forms of Protein X, and show whether the antibodies recognise both forms. </s><s n="s6.6;p11.13">The predicted result would be that only one form of the protein X would be recognised as monoclonal antibodies can only recognise one part of the protein, and therefore cannot differentiate between the two. </s></p></div1><div1 type="section"><head rend="bold">9) </head><p n="p12.13"><s n="s1.1;p12.13">It is a good idea to test the serum of an animal for antibodies against a protein of interest before injecting it with the antigen, as once it has been injected it could cause the antibodies to agglutinate in the blood in the presence of the antigen. </s></p></div1><div1 type="section"><head rend="bold">10) </head><p n="p13.13"><s n="s1.5;p13.13">The production of polyclonal antibodies usually requires a large amount of pure protein, whereas monoclonal antibodies require smaller amounts of impure protein. </s><s n="s2.5;p13.13">This is due to the fact that polyclonal antibodies are produced by many different B lymphocytes, and polyclonal preparations contain a mixture of antibodies that recognise different parts of the protein. </s><s n="s3.5;p13.13">This means that more amounts of pure protein will be needed in order to segregate the specific polyclonal antibody needed. </s><s n="s4.5;p13.13">In contrast, monoclonal antibodies are synthesized by identical B cells grown in cell culture, of which all recognise the same part of the protein. </s><s n="s5.5;p13.13">Therefore the same amount of antibodies would be produced, regardless of the volume or purity of the protein used for production. </s></p></div1></body><back/></text></TEI.2>
